Carlos Iribarren to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Carlos Iribarren has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.117
-
Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab. J Allergy Clin Immunol. 2014 Sep; 134(3):560-567.e4.
Score: 0.117